Home / Health / Shingles Shot May Ward Off Dementia, Study Finds
Shingles Shot May Ward Off Dementia, Study Finds
14 Feb
Summary
- Shingles vaccine shows a 20% reduction in dementia risk.
- Vaccine may also lower inflammation and improve healthy aging.
- Research suggests the vaccine averts one in five new dementia diagnoses.

Emerging research suggests that the shingles vaccine, commonly administered to individuals between 65 and 80, may significantly slow cognitive decline and reduce dementia risk. In 2021, an estimated 57 million people worldwide lived with dementia, highlighting the critical need for preventative measures.
Recent studies, including one analyzing data from 464,000 residents in Ontario, Canada, and populations in Australia, New Zealand, and Wales, found that the shingles vaccine reduced the incidence of dementia and mild cognitive impairment. Researchers estimate this protective effect averts approximately one in five new dementia diagnoses over a seven-year span.




